Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.600 | None | 0.990 | 28 | 0 | 2007 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.700 | None | 0.976 | 16 | 0 | 1989 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.979 | 7 | 0 | 1989 | 2020 | ||||||||
|
EMAP like 4 | 0.569 | 0.577 | 4.8E-04 |
|
disease | 0.400 | None | 0.994 | 6 | 0 | 2007 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.972 | 4 | 0 | 1990 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.600 | None | 0.986 | 4 | 0 | 2002 | 2020 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.400 | None | 0.989 | 4 | 0 | 2009 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.917 | 2 | 0 | 1999 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.957 | 2 | 0 | 1994 | 2020 | ||||||||
|
amphiregulin | 0.487 | 0.769 | 0.35 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.600 | None | 0.962 | 2 | 0 | 2006 | 2020 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2008 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
solute carrier family 34 member 2 | 0.656 | 0.423 | 9.4E-11 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.400 | None | 0.963 | 2 | 0 | 2002 | 2020 | ||||||||
|
neuronatin | 0.633 | 0.538 | 0.40 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
AXL receptor tyrosine kinase | 0.489 | 0.615 | 1.3E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
microRNA 346 | 0.631 | 0.615 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
apoptosis and caspase activation inhibitor | 0.760 | 0.231 | 2.7E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
matrix metallopeptidase 11 | 0.542 | 0.692 | 2.4E-05 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2014 | ||||||||
|
paxillin | 0.547 | 0.654 | 8.2E-02 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
zinc finger protein 462 | 0.711 | 0.462 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 |